• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌的介入治疗。

Interventional therapies for hepatocellular carcinoma.

机构信息

University of Michigan, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA.

出版信息

Cancer Imaging. 2012 Apr 5;12(1):79-88. doi: 10.1102/1470-7330.2012.0011.

DOI:10.1102/1470-7330.2012.0011
PMID:22487698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3335329/
Abstract

Hepatocellular carcinoma is the third most common cause of cancer-related death. In the past few years, staging systems have been developed that enable patients to be stratified into treatment algorithms in a multidisciplinary setting. Several of these treatments involve minimally invasive image-guided therapy that can be performed by radiologists.

摘要

肝细胞癌是癌症相关死亡的第三大常见原因。在过去的几年中,已经开发出了分期系统,使患者能够在多学科环境中分层为治疗算法。其中一些治疗方法涉及可以由放射科医生进行的微创图像引导治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/cb6dbbcffb4b/ci12001106.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/fbf82812edd0/ci12001101.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/e06798d44abf/ci12001102.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/fa19e702eac9/ci12001103.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/930d204e553c/ci12001104.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/4a19fadd4bb2/ci12001105.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/cb6dbbcffb4b/ci12001106.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/fbf82812edd0/ci12001101.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/e06798d44abf/ci12001102.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/fa19e702eac9/ci12001103.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/930d204e553c/ci12001104.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/4a19fadd4bb2/ci12001105.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f76/3335329/cb6dbbcffb4b/ci12001106.jpg

相似文献

1
Interventional therapies for hepatocellular carcinoma.肝癌的介入治疗。
Cancer Imaging. 2012 Apr 5;12(1):79-88. doi: 10.1102/1470-7330.2012.0011.
2
Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: a three-year randomized clinical trial.阿拉伯木聚糖米糠(MGN-3)增强了肝细胞癌介入治疗的效果:一项为期三年的随机临床试验。
Anticancer Res. 2010 Dec;30(12):5145-51.
3
New interventions for liver tumors.肝脏肿瘤的新干预措施。
Semin Roentgenol. 2002 Oct;37(4):303-11. doi: 10.1016/s0037-198x(02)80007-4.
4
Downstaging hepatocellular carcinoma prior to liver transplantation.肝移植前降低肝细胞癌分期
Liver Transpl. 2005 Dec;11(12):1466-8. doi: 10.1002/lt.20528.
5
[Nonsurgical management of hepatocellular carcinoma].肝细胞癌的非手术治疗
Cancer Radiother. 2010 Oct;14(6-7):469-73. doi: 10.1016/j.canrad.2010.07.228. Epub 2010 Aug 23.
6
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.肝细胞癌:局部区域治疗的现代方法。
Am J Gastroenterol. 2020 Nov;115(11):1733-1736. doi: 10.14309/ajg.0000000000000931.
7
Hepatic embolotherapy in interventional oncology: technology, techniques, and applications.介入肿瘤学中的肝栓塞治疗:技术、技术和应用。
Clin Radiol. 2013 Jan;68(1):1-15. doi: 10.1016/j.crad.2012.06.112. Epub 2012 Aug 20.
8
Use of yttrium-90 microspheres (TheraSphere) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: a case report.钇-90微球(TheraSphere)用于一名不可切除肝细胞癌患者并导致肝移植:病例报告。
Liver Transpl. 2005 Sep;11(9):1127-31. doi: 10.1002/lt.20514.
9
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.肝细胞癌的肝动脉化疗栓塞术:不同栓塞剂的生存率比较
J Vasc Interv Radiol. 2005 Dec;16(12):1661-6. doi: 10.1097/01.RVI.0000182160.26798.A2.
10
Contemporary management of hepatocellular carcinoma.肝细胞癌的当代管理
Clin Med (Lond). 2008 Aug;8(4):442-7. doi: 10.7861/clinmedicine.8-4-442.

引用本文的文献

1
CUL1-neddylation contributes to K29-linked ubiquitination on p27 for autophagic degradation in sorafenib-resistant liver cancer.CUL1的NEDD化修饰促进p27上K29连接的泛素化,以介导索拉非尼耐药肝癌中的自噬降解。
Cell Biol Toxicol. 2025 Mar 20;41(1):61. doi: 10.1007/s10565-025-10008-8.
2
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathway.UBE2Q2通过NF-κB/HIF1α信号通路促进肝细胞癌的肿瘤进展和糖酵解。
Cell Oncol (Dordr). 2025 Jun;48(3):637-654. doi: 10.1007/s13402-025-01037-w. Epub 2025 Jan 20.
3
CT-guided biopsies of unspecified suspect intrahepatic lesions: pre-procedure Lipiodol-marking improves the biopsy success rate.

本文引用的文献

1
Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study.肝硬化肝癌的手术切除与局部消融治疗:一项倾向病例匹配研究结果。
J Gastrointest Surg. 2012 Feb;16(2):301-11; discussion 311. doi: 10.1007/s11605-011-1745-x. Epub 2011 Nov 18.
2
Hepatocellular carcinoma: screening and staging.肝细胞癌:筛查和分期。
Clin Liver Dis. 2011 May;15(2):323-34, vii-x. doi: 10.1016/j.cld.2011.03.003.
3
Optimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and dose.
CT 引导下不明原因肝内可疑病变活检:术前碘化油标记可提高活检成功率。
Radiol Oncol. 2023 Jun 21;57(2):158-167. doi: 10.2478/raon-2023-0024. eCollection 2023 Jun 1.
4
Up-regulation of CLIC1 activates MYC signaling and forms a positive feedback regulatory loop with MYC in Hepatocellular carcinoma.CLIC1的上调激活MYC信号通路,并在肝细胞癌中与MYC形成正反馈调节环。
Am J Cancer Res. 2020 Aug 1;10(8):2355-2370. eCollection 2020.
5
Goals and targets for personalized therapy for HCC.肝癌个体化治疗的目标和靶点。
Hepatol Int. 2019 Mar;13(2):125-137. doi: 10.1007/s12072-018-9919-1. Epub 2019 Jan 1.
6
Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma following Transarterial Chemoembolization: Is It Helpful for Tumor Response?经动脉化疗栓塞后肝细胞癌残余肿瘤的超声造影:有助于肿瘤反应评估吗?
Biomed Res Int. 2018 Aug 2;2018:8632069. doi: 10.1155/2018/8632069. eCollection 2018.
7
Living . deceased-donor liver transplantation for patients with hepatocellular carcinoma.肝细胞癌患者的活体及尸体供肝肝移植
Transl Gastroenterol Hepatol. 2016 May 4;1:35. doi: 10.21037/tgh.2016.04.03. eCollection 2016.
8
miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7.微小RNA-935通过靶向SOX7促进肝癌细胞增殖和迁移。
Oncol Res. 2017 Mar 13;25(3):427-435. doi: 10.3727/096504016X14747300207374. Epub 2016 Sep 30.
9
miRNA-135a promotes hepatocellular carcinoma cell migration and invasion by targeting forkhead box O1.微小RNA-135a通过靶向叉头框O1促进肝癌细胞的迁移和侵袭。
Cancer Cell Int. 2016 Aug 2;16:63. doi: 10.1186/s12935-016-0328-z. eCollection 2016.
10
Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor.用于实体瘤近距离放疗和光动力治疗联合的时空光辐射控制瘤内储库
Biomaterials. 2016 Feb;79:79-87. doi: 10.1016/j.biomaterials.2015.11.064. Epub 2015 Dec 2.
阿霉素微球治疗肝细胞癌的最佳技术与反应:微球大小和剂量
Korean J Hepatol. 2011 Mar;17(1):51-60. doi: 10.3350/kjhep.2011.17.1.51.
4
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.经动脉(化疗)栓塞治疗不可切除的肝细胞癌。
Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD004787. doi: 10.1002/14651858.CD004787.pub2.
5
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.一项比较符合米兰标准的 HCC 的射频消融与手术切除的随机临床试验。
Ann Surg. 2010 Dec;252(6):903-12. doi: 10.1097/SLA.0b013e3181efc656.
6
Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?经导管动脉化疗栓塞治疗肝癌:是否到了区分常规与载药化疗栓塞的时候了?
Cardiovasc Intervent Radiol. 2011 Feb;34(1):37-49. doi: 10.1007/s00270-010-0012-y. Epub 2010 Nov 12.
7
Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.钇-90 微球在晚期肝细胞癌伴门静脉血栓形成患者中的应用。
J Vasc Interv Radiol. 2010 Sep;21(9):1377-84. doi: 10.1016/j.jvir.2010.04.027. Epub 2010 Aug 5.
8
Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.中大型肝细胞癌患者的中期结果:一项随机对照试验,旨在确定射频消融联合经导管动脉化疗栓塞的疗效。
Cancer. 2010 Dec 1;116(23):5452-60. doi: 10.1002/cncr.25314. Epub 2010 Jul 29.
9
Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).比较不可切除肝细胞癌(HCC)的传统经动脉化疗栓塞(TACE)与多柔比星载药微球(DEB)化疗栓塞。
J Surg Oncol. 2010 May 1;101(6):476-80. doi: 10.1002/jso.21522.
10
Current strategy for staging and treatment: the BCLC update and future prospects.当前的分期和治疗策略:BCLC 更新及未来展望。
Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19.